ABCC3 and colon carcinoma: This has been demonstrated in other cell models, in which MRP3 was described as being capable of transporting lysophosphatidylinositol (LPI) in colon carcinoma cells and activating the GPCR signaling cascade; this leads to increased proliferation, clonal expansion, and, consequently, progression of pathology [67].